Navigation Links
Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study

* Glivec found to dramatically reduce the risk of cancer returning after surgery for Kit-positive gastrointestinal stromal tumors (GIST)

* Patients receiving placebo in this trial will now be offered Glivec

* Global regulatory submissions planned for use of Glivec as adjuvant therapy in GIST patients following surgery to remove primary tumor

* Glivec already approved as effective therapy for patients with advanced metastatic or inoperable Kit-positive GIST

BASEL, Switzerland, April 12, 2007 - Investigators will begin offering Glivec® (imatinib)[*] to patients receiving placebo in a major North American clinical trial after after an interim analysis showed participants with Kit-positive gastrointestinal stromal tumors treated with Glivec following surgery were significantly less likely to experience a return of their cancer compared to those not taking this innovative therapy.

The interim analysis showed no recurrence of cancer in approximately 97% of patients given Glivec for a year after surgery to remove tumors, compared to approximately 83% of those who underwent surgery but received a placebo. The investigators made these results public because the study had met its primary endpoint in terms of the rate of recurrence-free survival.

The study involving more than 600 patients was sponsored by the National Cancer Institute (NCI), which is part of the US National Institutes of Health (NIH). It was conducted at multiple cancer centers in the US and Canada, and was led by the American College of Surgeons Oncology Group. Novartis supplied Glivec for use in the study, and also provided partial funding under a Cooperative Research and Development Agreement with NCI to support the clinical development of Glivec.

Glivec has already been confirmed as an effective therapy in its approved use for patients with advanced metastatic or unresectable (inoperable) Kit-positi
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

Post Your Comments:
(Date:11/9/2009)..., POTOMAC FALLS, Va., Nov. 9 Tess...croarray-based applications, announces the launch ...sting of the mutations that underlie human heredit...tise in microarray-based resequencing with novel n...ysis software enables screening for all targeted m...
(Date:11/9/2009)..., PALO ALTO, Calif., Nov. 9 Women... it has changed its name to Viveve as it prepares ...in select U.S. markets. ,, "Viveve is a name th...focus on women,s sexual health," said Kerry Pope, ...ists for the sole purpose of helping women restore...
(Date:11/9/2009)..., VIRGINIA BEACH, Va., Nov. 9 Lif...ny, announces the launch of Vertigraft Cervical Bi..., Preservon® is a new, proprietary glycero...t bio-implants to be stored in a fully hydrated st...ed to freeze or freeze-dry bio-implants, doing awa...
Breaking Medicine Technology:TessArae Delivers Lower Cost Option to Genetic Testing Market 2Women's Sexual Health Company Changes Name in Preparation for Market Entry 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 1CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 3Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 1Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 2ParagonRx Sponsors Webinar on Demand By DSEC on Role of Drug Safety Officers 13507 1
(Date:11/9/2009)...why this is so, however , , MONDAY, No... with very dense breasts have a higher risk of can... shows. , Breast density has already been linke...er, and experts have suspected that very dense bre... of cancer recurrence at the site of the original ...
(Date:11/9/2009)...wire-USNewswire/ -- Speaker Nancy Pelosi released...e Affordable Health Care for America Act (H.R....duce Medicare Part D costs for people living with ...y a vote of 220 to 215: ,, "Effective drug tre...ife for thousands of Americans living with HIV/AID...
(Date:11/9/2009)...PRNewswire/ -- Abt Associates continues to broad...ergency management consulting and support services...the work of the Federal Emergency Management Agenc...onal Commission on Children and Disasters and the ...ATA). The value of the combined contracts is appr...
(Date:11/9/2009)...mental Procedure for Preteen Son - ,, PHILADE...ts of children with cancer, the hopeful news is th... for decades. Among the bad news -- treatments tha... Boys diagnosed with cancer who have reached puber... fertility: before undergoing cancer treatment, th...
(Date:11/9/2009)...wire-USNewswire/ -- The American Academy of Physic...00 clinically practicing physician assistants (PAs...S. House of Representatives for passing Saturday i...ble Health Care for America Act. ,, "We are esp...ately lower the cost of health care and greatly ex...
Breaking Medicine News(10 mins):Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2
...hildren that jumping for joy can hurt them, accord...ship Children's Hospital, Auckland, have called fo...rising number of children being injured while jump...ncrease in pre-Christmas trampoline sales, compare...
...bviously a difficult question to answer. //There i...ving stem cell research that this is a fast growin... medicine. Ideally a properly funded nation... to us because that is not an option for them: the...
... dietary regime which will include lots of green v...amount of calcium. This type of food guide is the ...od Guide has addressed this guide to all the Canad...rescribed by the Food Guide may affect the sale of...
...ng blood loss in patients undergoing cardiac surge...during five years following// the surgery, accordi...ed for use in high-risk patients needing coronary ...ave received aprotinin since 1985, principally dur...
...ive compounds that stimulate white blood cell prod...herapy are at an increased// risk of developing a ...stic syndrome, according to a new study in the Feb...be taken into consideration when making treatment ...
...es Network (SIGN) has published a set of guideline...00 cardiovascular complaints// like heart attacks ... aims to provide preventive treatment to about 500...ms to provide lifestyle advice. As per the g...
Other Medicine News:Health News:Drug Used in Coronary Artery Bypass Surgery may Increase Risk of Death 2Health News:Growth Factors Given With Chemotherapy may Increase Risk of Blood Diseases 2Health News:Growth Factors Given With Chemotherapy may Increase Risk of Blood Diseases 3Health News:A New Plan to Restrict Cardiovascular Diseases in Scotland 2
L-Hook Electrode
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
...uments incorporate a layered design unique in the ...ed to prevent stray electrosurgical burns along th...lure or capacitive coupling; a well-documented pat... all AEM Instruments provides a neutral return pat...
Medicine Products: